CoronaryAtlas logo
CoronaryAtlas
microRNA-210
Pathway / Lipid retention & oxidation

microRNA-210

MIR210rna

miR-210 suppresses lipid-oxidation pathways and promotes hypoxic responses, modulating plaque lipid metabolism and inflammation.

Pathway placement
Cascade stepLipid retention & oxidation
Confidencemedium
RationaleRegulates metabolic genes; dysregulation alters lipid metabolism and hypoxia response in atherosclerotic lesions.
Also acts inVascular inflammation
Druggability
DruggableNo
Known drugs / candidates0
Small-molecule tractableNo
Antibody tractableNo
EnsemblENSG00000199038

Type I vs non-Type I discrimination

ScoresLow-confidence (proxy)
R — rupture / Type-I
20
C — non-Type-I
74
A — assay feasibility
50
E — evidence strength
28
T1DI (composite)
3
Specificity differential (R−C)-54.2
Non-Type-I axis panel
Does this marker also move in each non-Type-I setting? mag 0–3; higher means less Type-I-specific. n/a = no evidence retrieved, which is not the same as no change.
No non-Type-I axis evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood or cell-free plasma
Collection tube
PAXgene/Tempus RNA tube · K2/K3-EDTA (lavender-top)
Method / principle
RT-qPCR (TaqMan) or small-RNA sequencing
Reagent / substrate
Target-specific primers/probe; reverse transcriptase (miRNA: stem-loop RT primer)
Platform
qPCR instrument / NGS
Turnaround · availability
Research / send-out · Research (few LDTs)

Literature evidence(1)